Scandinavian ChemoTech AB (publ) reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported sales was SEK 1.18 million compared to SEK 0.072 million a year ago. Revenue was SEK 1.18 million compared to SEK 0.044 million a year ago. Net loss was SEK 6.38 million compared to SEK 5.96 million a year ago. Basic loss per share from continuing operations was SEK 0.48 compared to SEK 0.62 a year ago.
For the six months, sales was SEK 1.24 million compared to SEK 0.127 million a year ago. Revenue was SEK 1.24 million compared to SEK 0.14 million a year ago. Net loss was SEK 11.42 million compared to SEK 10.68 million a year ago. Basic loss per share from continuing operations was SEK 0.9 compared to SEK 1.11 a year ago.